This page shows the latest CRISPR news and features for those working in and with pharma, biotech and healthcare.
As humans, we are a great example. With our big brains, speech and cultures, we can invent CRISPR and send satellites out of the solar system.
short palindromic repeats (CRISPR) technology, which is used as a means of gene editing and enables scientists to manipulate DNA. ... Particularly critical to this effort was the newly developed ability to use CRISPR to replace immune receptors in
The study, published in the journal Cancer Research, involved the use of the gene editing technology CRISPR to break or switch off each of 25, 000 genes in cancer cells treated
ArsenalBio’s engineering platform spans a range of cutting-edge technology, including high-throughput CRISPR-based gene editing, synthetic biology and computational biology, to create new synthetic biological programmes aimed at
The ELIMINATE trial of LBP-EC01 – a CRISPR-enhanced bacteriophage (crPhage) precision medicine – in combination with a commonly used antibiotic will enrol approximately 800 female patients between 18-65 years of ... Paul Garofolo, co-founder and
Widely used ex vivo therapeutic gene-editing techniques such as CRISPR/Cas9 require cells to be removed from the body, edited and reinserted, in a lengthy, expensive and potentially hazardous process.
More from news
Approximately 16 fully matching, plus 37 partially matching documents found.
We can actually make it easier for patients to get the best from the amazing innovation, such as gene therapy and CRISPR, that is coming through.”.
With the introduction of new data analytics capabilities and broader adoption in the pharmaceutical industry, research platforms that heavily depend on data (eg, RNAi and CRISPR therapies) will likely increase their
Horizon Delivery is also an industry leader in CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) screenings, meaning they can identify key genes or genetic sequences that draw out specific functions of
cells engineered to display chimeric antigen receptors) and genome editing (ie, CRISPR/Cas, TALEN, ZNF).
Pioneers in the field include some notable women – such as CRISPR’s co-developers Jennifer Doudna and Emmanuelle Charpentier – although women remain in the minority in both the R&D and
More from intelligence
Approximately 2 fully matching, plus 18 partially matching documents found.
Lundberg most recently served as chief scientific officer of CRISPR Therapeutics, where he lead the development of the company’s first clinical trial application. ... Prior to CRISPR, he worked as head of translational medicine at Alexion
Their recent rapid advances of the CRISPR field highlight their ability to execute on deep technology with a multidisciplinary, informatics-first approach.
He becomes chief financial officer. CRISPR Therapeutics has appointed Marc Becker as its new chief financial officer with remit to drive development of its gene-editing technology platform. ... Becker said: “I am excited to join the CRISPR Therapeutics
Swiss biopharma company CRISPR Therapeutics has appointed Dr Tony Coles to its board of directors. ... Rodger Novak, chief executive officer of CRISPR Therapeutics, said: “Dr Coles is a venerated leader in the biotech industry with a strong track
More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.
Patient and market access insights on leveraging CRISPR technology for hematologic diseases.
With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. ... In October 2022, the companies announced their plan to file exagamglogene
Jessica Schwaber, Scientific Director, Cell &Gene Therapy, Avectas, explores her company’s unique cell engineering platform, the recent shift in cell &gene therapy commercial needs, current barriers to realizing the full potential of cell &gene
Creative Animodel is an experienced bioscience CRO,which would like to help you accelerate the process through preclinical services including transgenic animals, animal models of disease, CRISPR genome editing technology and
With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access.
More from PMHub
Approximately 3 fully matching, plus 2 partially matching documents found.
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....